4//SEC Filing
Robb Gary Charles 4
Accession 0000950170-25-076417
CIK 0001088856other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:48 PM ET
Size
10.0 KB
Accession
0000950170-25-076417
Insider Transaction Report
Form 4
Robb Gary Charles
Chief Financial Officer
Transactions
- Gift
Common Stock
2025-05-20+360→ 11,571 total(indirect: By Children) - Sale
Common Stock
2025-05-20$75.85/sh−2,279$172,862→ 16,586 total - Gift
Common Stock
2025-05-20−1,380→ 15,206 total - Gift
Common Stock
2025-05-20+360→ 11,571 total(indirect: By Children)
Footnotes (2)
- [F1]Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F2]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001529655
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:48 PM ET
- Size
- 10.0 KB